Quantcast
Last updated on April 24, 2014 at 14:55 EDT
Michigan Man Becomes Fourth Person In US To Receive Bionic

Michigan Man Becomes Fourth Person In US To Receive Bionic Eye

Brett Smith for redOrbit.com - Your Universe Online When Michigan resident Roger Pontz lost his eyesight due to a hereditary disease called retinitis pigmentosa, he probably never expected to seen again. However, Pontz is now seeing faint...

Latest Retina Stories

2014-04-24 08:35:50

Renowned ophthalmic expert to provide critical guidance to MacuLogix HUMMELSTOWN, Pa., April 24, 2013 /PRNewswire/ -- MacuLogix, Inc., a pioneer in the early detection and tracking of age-related macular degeneration (AMD), today announced the appointment of Joan W. Miller, MD FARVO as a Clinical Advisor. Dr. Miller will provide MacuLogix with guidance on the development and commercialization of the Company's AdaptDx®, an advanced dark adaptometer used by eye care physicians to...

2014-04-22 08:28:14

Innovative, Tissue-Sparing, Cost-Effective Therapy MOUNTAIN VIEW, Calif., April 22, 2014 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that an educational story based on its innovative MicroPulse(TM) technology for the treatment of diabetic macular edema (DME) and age-related macular degeneration (AMD), was recently featured on the Washington, D.C. edition of "American Health Front," a health news program focused on advances in medical techniques and technologies....

2014-04-17 15:26:52

Indiana University researchers have detected new early-warning signs of the potential loss of sight associated with diabetes. This discovery could have far-reaching implications for the diagnosis and treatment of diabetic retinopathy, potentially impacting the care of over 25 million Americans. "We had not expected to see such striking changes to the retinas at such early stages," said Ann Elsner, professor and associate dean in the IU School of Optometry and lead author of the study. "We...

2014-04-15 16:28:05

SARATOGA, Calif., April 15, 2014 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration, today announced two changes to its Board of Directors. Ophthalmic industry veteran, Mark Forchette has joined the board in a new seat; John Ryan is filling ONSET Ventures existing board seat. Mark Forchette brings thirty years of experience in ophthalmic sales, marketing and business unit...

2014-04-06 20:20:30

Leading Ophthalmologists Provide an Update on Breakthroughs in Artificial Vision Research TOKYO, April 6, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that Professor Eberhart Zrenner, M.D., coordinating investigator and founding director of the Institute for Ophthalmologic Research at University Eye Hospital, Tuebingen, Germany, presented an update on breakthroughs in artificial...

2014-04-03 11:04:31

Scientists at Trinity College Dublin have made a major breakthrough with important implications for sufferers of the eye disease Age-Related Macular Degeneration (AMD), which can cause central blindness in sufferers. The scientists found that a component of the immune system, 'IL-18', acts as a guardian of eyesight by suppressing the production of damaging blood vessels behind the retina at the back of the eye. In addition, in pre-clinical models, it was shown that 'IL-18' can be...

2014-04-01 16:25:30

Welch brings more than 25 years of leadership and global healthcare industry expertise to IRIS as the company expands its regional and national footprint PENSACOLA, Fla., April 1, 2014 /PRNewswire/ -- IRIS: Intelligent Retinal Imaging Systems, the country's preeminent cloud-based retinal screening technology provider, announced today that Pat Welch has joined its leadership team as Vice President of Healthcare Accounts. "Pat brings to the IRIS team more than 25 years of in-depth,...

2014-03-26 11:32:37

New research in the FASEB Journal suggests that the complement system allows the body to identify abnormal vessels and specifically target them for removal without damaging healthy cells A new report published online in The FASEB Journal may lead the way toward new treatments or a cure for a common cause of blindness (proliferative retinopathies). Specifically, scientists have discovered that the body's innate immune system does more than help ward off external pathogens. It also helps...

2014-03-26 04:21:03

PARIS, March 25, 2014 /PRNewswire/ -- Pixium Vision ("Pixium"), a developer of innovative Vision Restoration Systems for the blind, today announces the appointment of Khalid Ishaque as Chief Executive Officer and Director. Mr Ishaque joins from Boston Scientific, and brings over 22 years of management experience in the medical technology industry. Mr Ishaque spent 17 years with Boston Scientific Corporation, where most recently he was General Manager of its...

2014-03-24 12:30:49

LONDON, March 24, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Analysis of the US Retinal Therapeutics Market Improvements in Administration and Efficacy Drive GrowthSince the introduction of Lucentis in 2006, vascular endothelial growth factor (VEGF) antagonists have become the clear choice in treatment for age related macular degeneration, diabetic macular edema, and retinal vein occlusion due to their high efficacy and safety. This research...